Speakers
Despite the remarkable insights gleaned into the genetic origins of many diseases, diagnostics has remained the poor cousin of the biopharma ecosystem in many respects, its true value broadly underappreciated. However, the COVID-19 pandemic underscored the critical nature of rapid and accurate diagnosis. Solid diagnostic markers can help companies advance innovative treatments through clinical trials and identify patients who will most benefit from treatment. Early diagnosis can lead to better outcomes for patients, and in some cases, save lives.
Michael Ward caught up with three leaders from the diagnostics industry to examine the challenges the sector faces and opportunities for the companies able to navigate those challenges successfully.
The current and future state of diagnostics unfolds in our on-demand webinar – thoughtfully divided into sections to make it easy to explore the topics that matter most to you:
- 00:00 Introduction – Meet our panel of industry leaders
- 06:06 Industry lessons and outcomes from the pandemic
- 13:08 Diagnostics’ role in the drive toward precision medicine
- 16:46 Benefits to patients and healthcare systems
- 25:28 Diagnostics industry challenges
- 39:56 Innovations – what are the new frontiers in diagnostics
